FDA Approves New Antibiotic for Three Different Uses
The FDA approved a new antibiotic for the treatment of certain patients with Staphylococcus aureus bloodstream infections, including those with right-sided infective endocarditis; acute bacterial skin and skin structure infections; and community-acquired bacterial pneumonia. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 3, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Basilea Announces FDA Acceptance of New Drug Application for Antibiotic Ceftobiprole
Seeking approval for Staphylococcus aureus bacteremia (SAB), acute bacterial skin and skin structure infections (ABSSSI), and community-acquired bacterial pneumonia (CABP) Prescription Drug User Fee Act (PDUFA) goal date set for April 03,... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - October 2, 2023 Category: Drugs & Pharmacology Source Type: news

New Antibiotic Could Help Fight Resistant Staph Infections
THURSDAY, Sept. 28, 2023 -- New research shows that an antibiotic effective for bacterial pneumonia also appears to fight treatment-resistant staph infections. The drug is ceftobiprole. It appeared successful in fighting methicillin-resistant staph... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 28, 2023 Category: General Medicine Source Type: news

New Antibiotic Ceftobiprole Could Help Fight Resistant Staph Infections
THURSDAY, Sept. 28, 2023 -- New research shows that an antibiotic effective for bacterial pneumonia also appears to fight treatment-resistant staph infections. The drug is ceftobiprole. It appeared successful in fighting methicillin-resistant staph... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 28, 2023 Category: General Medicine Source Type: news

New Antibiotic, Ceftobiprole, Could Help Fight Resistant Staph Infections
THURSDAY, Sept. 28, 2023 -- New research shows that an antibiotic effective for bacterial pneumonia also appears to fight treatment-resistant staph infections. The drug is ceftobiprole. It appeared successful in fighting methicillin-resistant staph... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 28, 2023 Category: General Medicine Source Type: news

Pneumonia, Not Just Inflammation, May Cause Severe COVID Pneumonia, Not Just Inflammation, May Cause Severe COVID
New research from Northwestern University and the University of Wisconsin, however, is pointing to bacterial pneumonia as the cause of many severe COVID deaths.WebMD Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - September 26, 2023 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

FDA Approves Xacduro for Difficult-to-Treat Bacterial Pneumonia
TUESDAY, May 30, 2023 -- The U.S. Food and Drug Administration has approved Xacduro (sulbactam for injection; durlobactam for injection) as a new treatment for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 30, 2023 Category: General Medicine Source Type: news

New Therapy OK'd for Drug-Resistant Pneumonia
(MedPage Today) -- The FDA has approved sulbactam-durlobactam (Xacduro) for healthcare-acquired bacterial pneumonia caused by certain strains of Acinetobacter baumannii-calcoaceticus complex (A. baumannii), the agency announced late on Tuesday... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - May 24, 2023 Category: American Health Source Type: news

All Thumbs Up From FDA Panel for Bacterial Pneumonia Therapy
(MedPage Today) -- An FDA advisory panel voted unanimously in favor of recommending that the FDA approve sulbactam-durlobactam for the treatment of adults with hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - April 18, 2023 Category: American Health Source Type: news

FDA Panel to Weigh Limited Data on Combo for Healthcare-Acquired Pneumonia
(MedPage Today) -- Data from small trials will determine whether an FDA advisory panel recommends the agency approve sulbactam‐durlobactam for hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by Acinetobacter... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - April 14, 2023 Category: American Health Source Type: news

Vape addict, 45, from Indiana coughs up THREE PINTS of blood
Dustin Fitzgerald, 45, (left) of Indiana was hospitalized when he began coughing up pints of blood. Doctors diagnosed him with bacterial pneumonia and attributed it to his vaping. (Source: the Mail online | Health)
Source: the Mail online | Health - February 27, 2023 Category: Consumer Health News Source Type: news

Iron Deficiency May Protect Against Bacterial Pneumonia Iron Deficiency May Protect Against Bacterial Pneumonia
Iron deficiency is the most common nutritional deficiency, but iron is also required for the survival and growth of pathogens, experts say.MDedge (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - October 21, 2022 Category: Emergency Medicine Tags: Infectious Diseases News Source Type: news

Navy SEAL candidate died of bacterial pneumonia in hours after Hell Week training, Navy investigation finds
Navy SEAL candidate Kyle Mullen, 24, died of bacterial pneumonia in the hours after completing what is known as "Hell Week" during the special operations force's demanding basic training program... #dutyinvestigation #navy #navyseal #investigation #kylemullen #training (Source: Reuters: Health)
Source: Reuters: Health - October 12, 2022 Category: Consumer Health News Source Type: news

Bacterial Pneumonia Patients With a Penicillin Allergy Label Face...
Penicillin allergy labels have negative consequences in bacterial pneumonia patients, when many with these labels can safely receive penicillin, according to new research published in an official...(PRWeb September 28, 2022)Read the full story at https://www.prweb.com/releases/bacterial_pneumonia_patients_with_a_penicillin_allergy_label_face_worse_clinical_outcomes/prweb18913818.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 28, 2022 Category: Pharmaceuticals Source Type: news

Researchers Target a Mouse ’s Own Cells, Rather Than Using Antibiotics, to Treat Pneumonia
Researchers at the National Institutes of Health have discovered a therapy that targets host cells rather than bacterial cells in treating bacterial pneumonia in rodents. (Source: NIEHS News)
Source: NIEHS News - November 15, 2021 Category: Environmental Health Source Type: news